Mari V Berthet P Castera L Vaur D Lallaoui H Bignon YJ Uhrhammer N Bonadona V Lasset C Révillion F Vennin P Muller D Gomes DM Ingster O Coupier I Pujol P Collonge-Rame MA Mortemousque I Bera O Rose M Baurand A Bertolone G Faivre L Dreyfus H Leroux D Venat-Bouvet L Bézieau S Delnatte C Chiesa J Gilbert-Dussardier B Gesta P Prieur FP Bronner M Sokolowska J Coulet F Boutry-Kryza N Calender A Giraud S Leone M Fert-Ferrer S Stoppa-Lyonnet D Jiao Y Lesueur FL Mebirouk N Barouk-Simonet E Bubien V Longy M Sevenet N Gladieff L Toulas C Reimineras A Sobol H Paillerets BB Cabaret O Caron O Guillaud-Bataille M Rouleau E Belotti M Buecher B Caputo S Colas C Pauw A Fourme E Gauthier-Villars M Golmard L Moncoutier V Saule C Donaldson A Murray A Brady A Brewer C Pottinger C Miller C Gallagher D Gregory H Cook J Eason J Adlard J Barwell J Ong KR Snape K Walker L Izatt L Side L Tischkowitz M Rogers MT Porteous ME Ahmed M Morrison PJ Brennan P Eeles R Davidson R Sexton A Christian A Trainer A Spigelman A Fellows A Shelling A Fazio A Blackburn A Crook A Meiser B Patterson B Clarke C Saunders C Hunt C Scott C Amor D Marsh D Edkins E Salisbury E Haan E Neidermayr E Macrea F Farshid G Lindeman G Trench G Mann G Giles G Gill G Thorne H Campbell I Hickie I Winship I Flanagan J Kollias J Visvader J Stone J Taylor J Burke J Saunus J Forbes J Hopper J Beesley J Kirk J French J Tucker K Wu K Phillips K Lipton L Andrews L Lobb L Walker L Kentwell M Spurdle M Cummings M Gleeson M Harris M Jenkins M Young MA Delatycki M Wallis M Burgess M Price M Brown M Southey M Bogwitz M Field M Friedlander M Gattas M Saleh M Hayward N Pachter N Cohen P Duijf P James P Simpson P Fong P Butow P Williams R Kefford R Scott R Milne R Balleine R Dawson SJ Lok S O'Connell S Greening S Nightingale S Edwards S Fox S McLachlan SA Lakhani S Antill Y Aalfs C Meijers-Heijboer H van Engelen K Gille H Boere I Collée M van Deurzen C Hooning M Obdeijn IM van den Ouweland A Seynaeve C Siesling S Verloop J van Asperen C Devilee P van Cronenburg T Blok R de Boer M Garcia EG Adank M Hogervorst F Jenner D van Leeuwen F Rookus M Russell N Schmidt M van den Belt-Dusebout S Kets C Mensenkamp A de Bock T van der Hout A Mourits M Oosterwijk J Ausems M Koudijs M Clarke C Marsh D Scott R Baxter R Yip D Carpenter J Davis A Pathmanathan N Simpson P Graham D Sachchithananthan M

¹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²Centre de Bioinformatique Biostatistique et Biologie Intégrative (C3BI), Institut Pasteur, Paris, France.
³Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁴Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁶Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁷Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁸Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁰Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
¹¹Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
¹²Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
¹³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁴Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁵Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁶Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
¹⁷Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
¹⁸Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV), IRCCS, Padua, Italy.
¹⁹Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²⁰Human Genotyping-CEGEN Unit, Human Cancer Genetic Program, Spanish National Cancer Research Centre, Madrid, Spain.
²¹Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
²²Department of Epidemiology, Genetic Epidemiology Research Institute, University of California, Irvine, Irvine, CA, USA.
²³N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
²⁴Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
²⁵Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁶Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
²⁷Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
²⁸Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
²⁹Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³⁰Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
³¹High Risk and Cancer Prevention Group, Vall Hebron Institute of Oncology, Barcelona, Spain.
³²Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
³³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³⁴Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
³⁵Centro de Investigación en Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
³⁶Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
³⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
³⁸Cancer Genetics and Prevention Program, University of California, San Francisco, San Francisco, CA, USA.
³⁹Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
⁴⁰Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
⁴¹N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
⁴²Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁴³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁴Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
⁴⁵Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
⁴⁶Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
⁴⁷Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
⁴⁸Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁹Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
⁵⁰Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
⁵¹Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
⁵²Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
⁵³Molecular Epidemiology Group (C080), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁵⁴Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
⁵⁵Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
⁵⁶Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
⁵⁷SOD Genetica Molecolare, University Hospital, Pisa, Italy.
⁵⁸Department of Internal Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
⁵⁹Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
⁶⁰Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁶¹Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
⁶²Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
⁶³Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
⁶⁴Axe Oncologie, Centre de Recherche, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Québec, Canada.
⁶⁵Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
⁶⁶Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
⁶⁷Centre for Medical Genetics, Ghent University, Ghent, Belgium.
⁶⁸Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
⁶⁹Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
⁷⁰Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁷¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁷²Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
⁷³Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
⁷⁴Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁷⁵Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁷⁶Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
⁷⁷Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
⁷⁸Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
⁷⁹Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
⁸⁰Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
⁸¹Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
⁸²Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
⁸³Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
⁸⁴Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
⁸⁵Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
⁸⁶Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
⁸⁷Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
⁸⁸Cáncer Hereditario, Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid Centro Superior de Investigaciones Científicas (UVA-CSIC), Valladolid, Spain.
⁸⁹Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
⁹⁰School of Life Sciences, University of Westminster, London, UK.
⁹¹Faculty of Medicine, University of Southampton, Southampton, UK.
⁹²Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
⁹³Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁹⁴Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁹⁵David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
⁹⁶Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
⁹⁷Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
⁹⁸Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁹⁹Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
¹⁰⁰Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
¹⁰¹The Suzanne Levy-Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
¹⁰²School of Public Health, Curtin University, Perth, Western Australia, Australia.
¹⁰³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁰⁴Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁰⁵Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
¹⁰⁶SOD Genetica Molecolare, University Hospital, Pisa, Italy.
¹⁰⁷Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Centre, University of California, Los Angeles, Los Angeles, CA, USA.
¹⁰⁸Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
¹⁰⁹Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
¹¹⁰Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
¹¹¹Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
¹¹²Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
¹¹³Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
¹¹⁴Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
¹¹⁵Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS, USA.
¹¹⁶Department of Medicine, McGill University, Montréal, Québec, Canada.
¹¹⁷Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹¹⁸Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
¹¹⁹U.O. Anatomia Patologica Ospedale di Circolo, ASST Settelaghi, Varese, Italy.
¹²⁰Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹²¹Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
¹²²Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹²³Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montréal, Québec, Canada.
¹²⁴Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Paris, France.
¹²⁵Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
¹²⁶Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹²⁷Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹²⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹²⁹Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³⁰Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹³¹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
¹³²Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
¹³³Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹³⁴Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹³⁵Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹³⁶School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia.
¹³⁷Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹³⁸Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹³⁹Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁴⁰Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁴¹Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
¹⁴²Division of Cancer Sciences, University of Manchester, Manchester, UK.
¹⁴³Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁴⁴Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
¹⁴⁵N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
¹⁴⁶Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
¹⁴⁷Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
¹⁴⁸Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁴⁹Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of North Macedonia.
¹⁵⁰Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁵¹Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
¹⁵²Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
¹⁵³Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
¹⁵⁴Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
¹⁵⁵Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
¹⁵⁶Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
¹⁵⁷Department of Oncology, Tampere University Hospital, Tampere University and Tampere Cancer Center, Tampere, Finland.
¹⁵⁸Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁵⁹Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁶⁰Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
¹⁶¹Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁶²David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
¹⁶³Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹⁶⁴Surgery, School of Medicine, National University of Ireland, Galway, Ireland.
¹⁶⁵Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
¹⁶⁶Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
¹⁶⁷Familial Cancer Service, Weatmead Hospital, Sydney, New South Wales, Australia.
¹⁶⁸Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
¹⁶⁹Department of Internal Medicine, Evangelische Kliniken Bonn, Johanniter Krankenhaus, Bonn, Germany.
¹⁷⁰Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
¹⁷¹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
¹⁷²Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹⁷³Department of Histopathology and Cytology, Clinical Hospital 'Acibadem Sistina', Skopje, Republic of North Macedonia.
¹⁷⁴Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
¹⁷⁵Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
¹⁷⁶The Suzanne Levy-Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
¹⁷⁷VIB Center for Cancer Biology, VIB, Leuven, Belgium.
¹⁷⁸Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁷⁹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁸⁰David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
¹⁸¹Institut Curie, Paris, France.
¹⁸²Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
¹⁸³Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
¹⁸⁴Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
¹⁸⁵Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
¹⁸⁶Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹⁸⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁸⁸Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
¹⁸⁹Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
¹⁹⁰Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
¹⁹¹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
¹⁹²Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁹³Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
¹⁹⁴Department of Oncology, Södersjukhuset, Stockholm, Sweden.
¹⁹⁵Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
¹⁹⁶Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
¹⁹⁷Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁹⁸Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
¹⁹⁹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁰⁰Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁰¹Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
²⁰²Institut Curie, Paris, France.
²⁰³Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.
²⁰⁴NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
²⁰⁵Surgery, School of Medicine, National University of Ireland, Galway, Ireland.
²⁰⁶Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV), IRCCS, Padua, Italy.
²⁰⁷Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
²⁰⁸Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
²⁰⁹Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
²¹⁰Radiation Oncology, Hospital Meixoeiro-XXI de Vigo, Vigo, Spain.
²¹¹Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²¹²Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
²¹³Department of Pathology, School of Medicine, Umm Al-Qura University, Holy Makkah, Saudi Arabia.
²¹⁴Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
²¹⁵Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
²¹⁶Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²¹⁷Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
²¹⁸Center for Genomic Medicine at Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
²¹⁹Latvian Biomedical Research and Study Centre, Riga, Latvia.
²²⁰Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
²²¹Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²²²Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
²²³Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
²²⁴Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
²²⁵Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
²²⁶Centro de Investigación en Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
²²⁷University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM, USA.
²²⁸Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
²²⁹Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
²³⁰Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
²³¹Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
²³²Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
²³³Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
²³⁴Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
²³⁵Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
²³⁶Genome Diagnostics Program, IFOM-the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
²³⁷Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
²³⁸Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of North Macedonia.
²³⁹Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
²⁴⁰Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
²⁴¹School of Life Sciences, University of Westminster, London, UK.
²⁴²Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia.
²⁴³ProCURE, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
²⁴⁴Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
²⁴⁵Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
²⁴⁶School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
²⁴⁷Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
²⁴⁸Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²⁴⁹Clalit National Israeli Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
²⁵⁰Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
²⁵¹Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²⁵²Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
²⁵³Center for Genomic Medicine at Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
²⁵⁴Department of Oncology, University Hospital of Larissa, Larissa, Greece.
²⁵⁵Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
²⁵⁶Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
²⁵⁷Centro de Investigación en Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
²⁵⁸School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
²⁵⁹Research Oncology, Guy's Hospital, King's College London, London, UK.
²⁶⁰Cancer Genetics and Prevention Program, University of California, San Francisco, San Francisco, CA, USA.
²⁶¹Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
²⁶²Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
²⁶³Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
²⁶⁴Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
²⁶⁵Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁶⁶Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
²⁶⁷Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
²⁶⁸Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.
²⁶⁹Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
²⁷⁰Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
²⁷¹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁷²Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA.
²⁷³Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
²⁷⁴Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
²⁷⁵Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
²⁷⁶Clinical Cancer Genomics, City of Hope, Duarte, CA, USA.
²⁷⁷University Clinic of Radiotherapy and Oncology, Medical Faculty, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
²⁷⁸Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
²⁷⁹Population Oncology, BC Cancer, Vancouver, British Columbia, Canada.
²⁸⁰Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
²⁸¹Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
²⁸²Department of Tumour Biology, INSERM U830, Paris, France.
²⁸³Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
²⁸⁴Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
²⁸⁵Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
²⁸⁶Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
²⁸⁷Faculty of Medicine, University of Southampton, Southampton, UK.
²⁸⁸Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
²⁸⁹Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
²⁹⁰Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
²⁹¹Breast Cancer Research Programme, Cancer Research Malaysia, Kuala Lumpur, Malaysia.
²⁹²Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
²⁹³Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
²⁹⁴Department of Clinical Genetics, Odense University Hospital, Odence, Denmark.
²⁹⁵Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
²⁹⁶Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
²⁹⁷Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
²⁹⁸Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
²⁹⁹Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
³⁰⁰Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
³⁰¹Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.
³⁰²Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³⁰³Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Paris, France.
³⁰⁴Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
³⁰⁵Department of Pathology, University Hospital of Heraklion, Heraklion, Greece.
³⁰⁶Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany.
³⁰⁷Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
³⁰⁸Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
³⁰⁹Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
³¹⁰Department of Genetics, University of Pretoria, Pretoria, South Africa.
³¹¹Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain.
³¹²Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
³¹³Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³¹⁴Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
³¹⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³¹⁶Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
³¹⁷Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, USA.
³¹⁸Clinical Cancer Genomics, City of Hope, Duarte, CA, USA.
³¹⁹Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
³²⁰Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
³²¹Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
³²²Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
³²³Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³²⁴Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
³²⁵Division of Clinical Epidemiology and Aging Research (C070), German Cancer Research Center (DKFZ), Heidelberg, Germany.
³²⁶Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
³²⁷Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³²⁸Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³²⁹Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³³⁰Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
³³¹Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
³³²Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
³³³Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
³³⁴Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³³⁵Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³³⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³³⁷Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³³⁸Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Québec City, Québec, Canada.
³³⁹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³⁴⁰Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. pkraft@hsph.harvard.edu.
³⁴¹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. amd24@medschl.cam.ac.uk.